Hyperhomocyst(e)inemia and elevated soluble vascular cell adhesion molecule-1 concentrations are associated with an increased risk of preeclampsia

Gynecologic and Obstetric Investigation

Volumn 58, Issue 3, 2004, Pages 133-139

  Vadachkoria, Surab ^a   Sanchez, Sixto E ^b   Qiu, Chunfang ^a   Muy Rivera, Martin ^a   Malinow, M Rene ^c   Williams, Michelle A ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b HOSPITAL NACIONAL DOS DE MAYO   (Peru)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Homocyst(e)ine; Pregnancy, sVCAM 1; Pregnancy, total plasma homocysteine; Soluble vascular cell adhesion molecule 1

Indexed keywords

HOMOCYSTEINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOTHESIS; LABOR; MATERNAL PLASMA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 5744231357     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079067     Document Type: Article

References (34)

1. Malinow MR: Hyperhomocyst(e)inemia: A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 1990;81:2004-2006.
2. Boushey CJ, Beresford S, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factors for vascular disease. JAMA 1995;274:1049-1057.
3. Moghadasian MH, McManus BM, Frohlich JJ: Homocysteine and coronary artery disease. Arch Intern Med 1997;157:2299-2308.
4. Rajkovic A, Catalano PM, Malinow MR: Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol 1997;90:168-171.
5. Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, Roberts JM: Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998;179:1605-1611.
6. Rajkovic A, Mahomed K, Malinow MR, Sorensen, Woelk GB, Williams MA: Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum. Obstet Gynecol 1999;94:355-360.
7. 12 and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol 2001;153:474-480.
8. Lopez-Quesada E, Vilaseca MA, Lailla JM: Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003;108:45-49.
9. Sorensen TK, Malinow MR, Williams MA, King IB, Luthy DA: Elevated second trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest 1999;48:98-103.
10. Cotter AM, Molloy AM, Scott JM, Daly SF: Elevated plasma homocysteine in early pregnancy: A risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001;185:781-785.
11. Murakami S, Matsubara N, Saitoh M, Miyakaw S, Shoji M, Kubo T: The relation between plasma homocysteine concentration and methylenetetrahydrofolate reductase gene polymorphism in pregnant women. J Obstet Gynaecol Res 2001;27:349-352.
12. Blann AD: Endothelial cell damage and homocysteine. Atherosclerosis 1992;94:89-91.
13. Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvoll K, Sandstad B, Hjermann I, Arnesen, H, Nenseter MS: Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. Eur J Clin Invest 1998;29:100-108.
14. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM: Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 2001;107:675-683.
15. Silverman MD, Tumiluri RJ, Davis M, Lopez G, Rosenbaum JT, Lelkes PI: Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 2002;22:587-592.
16. Wang G, Woo CWH, Sung FL, Siow YL, OK: Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: Role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol 2002;22:1777-1783.
17. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JCP: The cell adhesion molecule VCAM-1 is selectively elevated in serum of preeclampsia: Does this indicate the mechanism of leukocyte activation? Br J Obstet Gynaecol 1994;101:485-487.
18. Austgulen R, Lien E, Vince G, Redman CW: Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997;71:53-58.
19. Krauss T, Kuhn W, Lakoma C, Augustin HG: Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997;177:443-449.
20. Madazli R, Budak E, Calay Z, Aksu MF: Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in preeclampsia. Br J Obstet Gynaecol 2000;107:514-518.
21. Krauss T, Emons G, Kuhn W, Augustin HG: Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin Chem 2002;48:1418-1425.
22. Higgins JR, Papayianni A, Brady HR, Darling MR, Walshe JJ: Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: Evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in preeclampsia. Am J Obstet Gynecol 1998;179:464-469.
23. Clausen T, Djurovic S, Brosstad FR, Berg K, Henriksen T: Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: Indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000;182:321-325.
24. Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA: Plasma lipid concentrations in preeclamptic and normotensive Peruvian women. Int J Gynecol Obstet 1999;67:147-155.
25. American College of Obstetricians and Gynecologists: Hypertension in pregnancy. ACOG Tech Bull 1996;219:1-8.
26. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy: Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
27. Malinow RM, Sexton G, Averbuch M, Grossman M, Wilson D, Upson B: Homocyst(e)-inemia in daily practice: Levels in coronary artery disease. Coron Artery Dis 1990;1:215-220.
28. Hsieh CC, Maisonneuve P, Boyle P, Macfarlane GJ, Robertson C: Analysis of quantitative data by quantiles in epidemiologic studies: Classification according to cases, non-cases or all subjects. Epidemiology 1991;2:137-140.
29. Rothman KJ, Greenland S: Modern Epidemiology, ed 2. Philadelphia, Lippincott-Raven, 1998.
30. Dustin ML, Staunton DE, Springer TA: Supergene families meet the immune system. Immunol Today 1988;9:213-215.
31. Bevilacqua MP, Nelson RM: Selectins. J Clin Invest 1993;91:379-387.
32. Blundel G, Jones BG, Rose FA, Tudball N: Homocysteine-mediated endothelial cell toxicity and its amelioration. Atherosclerosis 1996;122:163-172.
33. Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky MS: Effects of homocysteine on endothelial nitric oxide production. Am J Physiol 2000;279:F671-F678.
34. Zhang C, Cai Y, Mimi T, Satoru O, Aso T, Kaufman RJ, Kitajima S: Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 2001;276:35867-35874.